Message aux signatairesDemand FDA Approval for Emergency Use of Ivermectin for Covid 19 Treatment

FDA panel narrowly recommends authorization of first antiviral pill to treat COVID

Diana ZFair Lawn, NJ, États-Unis

30 nov. 2021

November 30, 2021 – A US Food and Drug Administration (FDA) advisory panel narrowly voted 13 to 10 today to recommend emergency use authorization for the antiviral pill molnupiravir from Merck and Ridgeback Biotherapeutics to treat COVID-19.

Soutenir maintenant

Signez cette pétition

Copier le lien

Facebook

E-mail

N.J. hospitals have potent COVID treatments. But some doctors aren’t aware

COVID-19 pill gets advisory panel approval